Search results
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 1 day agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
Another COVID vaccine? Yes, and here’s why
Denver Post· 2 days agoNow, with four years of inoculations and infections, the general population has a wide range of vulnerabilities. While the vaccine is free to both...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 3 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 23 hours agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
What is COVID KP.3 variant? Symptoms, CDC data, what to know about the newest COVID strain
USA Today· 2 days agoThe Centers for Disease Control and Prevention said it is tracking the new COVID variant KP.3 as data shows its dominance across the United States. For the two-week period ...
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
FOX Business· 5 days agoA 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long ...
Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with...
Morningstar· 21 hours agoPfizer Inc. (NYSE: PFE) today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating the investigational mini-dystrophin ...
Feeling rough after your COVID shot? That's a sign it's working
Medical Xpress· 3 days agoStates have received last year's updated COVID-19 vaccine, despite a death toll of more than 23,000 Americans this year. One of the most ...
Indonesia ramps up fight against tuberculosis amid concerns on economic impact
Reuters via Yahoo News· 3 days agoIndonesia plans to run clinical trials of several vaccines to fight surging cases of tuberculosis...
There's another COVID variant you should know about: KP.3 now makes up 25% of COVID cases
USA Today· 5 days agoThe Centers for Disease Control and Prevention data shows that a new COVID variant, the KP.3...